Vitamin C Slows Cancer Down

[Guest guest]

FOR IMMEDIATE RELEASE

Orthomolecular Medicine News Service, October 31, 2008

Vitamin C Slows Cancer Down

And, Doctors Say, Can Reverse It as Well

_http://orthomolecular.org/resources/omns/v04n19.shtml_

(http://orthomolecular.org/resources/omns/v04n19.shtml)

(OMNS, October 31, 2008) The BBC recently reported (1) that " Vitamin C

'slows cancer growth.' An injection of a high dose of vitamin C may be able to

hold back the advance of cancers, US scientists claim. The vitamin may start a

destructive chain reaction within the cancer cell. " The injection " halved the

size " of tumors, and was reported in the Proceedings of the National Academy

of Sciences.

The study authors themselves said that daily, high-dose vitamin C treatment

" significantly decreased growth rates " of ovarian, pancreatic, and malignant

brain tumors in mice. Such high, cancer-stopping levels of vitamin C can be

" readily achieved in humans given ascorbate intravenously. " (2)

" Readily achieved " ? Then this is important, absolutely vital news for

millions fighting or fearing cancer.

So what do major cancer organizations have to say? Not much. That is

disappointing, but hardly surprising. Both the American Cancer Society and

Cancer

Research UK have downplayed or flatly ignored decades of physician reports and

controlled clinical studies indicating that vitamin C stops cancer. What's

worse, each of these supposedly comprehensive cancer research and education

organizations continues to actively discourage people from using vitamin C

against cancer.

Look for yourself and see. The American Cancer Society's vitamin C webpage

(3) specifically states: " Although high does of vitamin C have been suggested

as a cancer treatment, the available evidence from clinical trials has not

shown any benefit. " And Cancer Research UK states that " There is currently no

evidence from clinical trials in humans that injecting or consuming vitamin C

is an effective way to treat cancer. " (1)

" No benefit, " they say. " No evidence, " they say.

Both organizations are wrong. Neither statement is true.

In 2008, Korean doctors reported that intravenous vitamin C " plays a crucial

role in the suppression of proliferation of several types of cancer, "

notably melanoma. (4)

In 2006, Canadian doctors reported on the effectiveness of intravenous

vitamin C in treating cancer. (5)

In 2004, doctors in America and Puerto Rico published clinical cases of

vitamin C successes against cancer. (6)

In 1990, American doctors published their results successfully using vitamin

C to treat kidney cancer (7). In 1995 and 1996, other cancers. (8) Using

30,000 mg of intravenous vitamin C twice per week, they found that " metastatic

lesions in the lung and liver of a man with a primary renal cell carcinoma

disappeared in a matter of weeks. . . We subsequently reported a case of

resolution of bone metastases in a patient with primary breast cancer [1A]

using

infusions of 100 grams, once or twice per week. " (9)

In 1982, Japanese doctors showed that vitamin C greatly prolonged the lives

of terminal cancer patients. (10)

And as early as 1976, over two decades ago, physicians in Scotland showed

that intravenous vitamin C improved quality and length of life in terminal

cancer patients. (11)

Why are ACS and Cancer Research UK oblivious to the weight of evidence? All

these previous clinical reports were published in peer-reviewed medical

journals. One may bear in mind that both ACS and Cancer UK made their

restrictive

statements August 2008. Yes, 2008. In spite of increasingly compelling

evidence for 22 years, both the American Cancer Society and Cancer Research UK

are

dragging their feet. Foot-dragging costs lives. Hundreds of thousands of

people have died from cancer that could have been helped with ascorbate

therapy.

But for decades, their three advocated cancer treatments have been " cut, zap,

and drug " : surgery, radiation and chemotherapy. The use of high doses of

vitamins has been thoroughly excluded.

Indeed, ACS still says: " If a supplement is taken, the best choice for most

people is a balanced multivitamin/mineral supplement that contains no more

than 100% of the 'Daily Value' of most nutrients. " (3) That is harmful advice.

Many well designed clinical studies show that large doses of vitamin C and

other nutrients improve both quality and length of life for cancer patients.

The key is the use of sufficiently high quantities, appropriately administered.

More orange juice just won't do it.

Cancer Research UK even maintains (1) that vitamin C " can make cancer

treatment less effective, reducing the benefits of radiotherapy and

chemotherapy. "

That statement is untrue. (12,13) Oncologists routinely administer

antioxidant drugs along with chemotherapy with no diminution of effect. (14)

ACS and Cancer Research UK say that there is " no evidence from clinical

trials " that vitamin C is any good against cancer. They should start reading

the

medical literature. They are way behind the times. And they are wrong. Dead

wrong.

References:

(1) BBC NEWS: _http://news.bbc.co.uk/go/pr/fr/-/2/hi/health/7540822.stm_

(http://www.orthomolecular.org/12all/lt/t_go.php?i=101 & e=MjY2MDA= & l=http://news.\

bbc

..co.uk/go/pr/fr/-/2/hi/health/7540822.stm) Published: Aug 4, 2008.

 

(2) Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB,

Drisko J, Levine M. Pharmacologic doses of ascorbate act as a prooxidant and

decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S

A.

2008 Aug 4.

 

(3) _http://www.cancer.org/docroot/ETO/content/ETO_5_3X_Vitamin_C.asp_

(http://www.orthomolecular.org/12all/lt/t_go.php?i=101 & e=MjY2MDA= & l=http://www.c\

ancer

..org/docroot/ETO/content/ETO_5_3X_Vitamin_C.asp) (accessed Aug 12, 2008)

 

(4) Padayatty et al. Intravenously administered vitamin C as cancer therapy:

three cases. Canadian Medical Association Journal, 2006. 174(7), March 28, p

937-942. _http://www.cmaj.ca/cgi/reprint/174/7/937_

(http://www.orthomolecular.org/12all/lt/t_go.php?i=101 & e=MjY2MDA= & l=http://www.c\

maj.ca/cgi/reprint/174/7

/937)

 

(5) Lee SK, Kang JS, Jung da J et al. Vitamin C suppresses proliferation of

the human melanoma cell SK-MEL-2 through the inhibition of cyclooxygenase-2

(COX-2) expression and the modulation of insulin-like growth factor II

(IGF-II) production. J Cell Physiol. 2008 Jul;216(1):180-8.

 

(6) Riordan HD, Riordan NH, Jackson JA, Casciari, J.J., Hunninghake, R,

Gonzalez MJ, Mora, E.M., Miranda-Massari, J.R., Rosario, N., Rivera, A.:

Intravenous Vitamin C as a Chemotherapy Agent: a Report on Clinical Cases.

Puerto

Rico Health Sciences J, June 2004, 23(2): 115-118.

 

(7) Riordan HD, Jackson JA, 'Schultz M. Case study: high-dose intravenous

vitamin C in the treatment of a patient with adenocarcinoma of the kidney. J

Ortho Med 1990; 5: 5-7.

 

(8) Riordan N, Jackson JA, Riordan HD. Intravenous vitamin C in a terminal

cancer patient. J Ortho Med 1996; 11: 80-82. Also: Riordan, N. H., et al.

(1995) Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent.

Medical

Hypotheses, 44(3). p 207-213, March.

 

(9) Riordan NH, Riordan HD, Hunninghake RE. Intravenous ascorbate as a

chemotherapeutic and biologic response modifying agent.

_http://www.doctoryourself.com/riordan1.html_

(http://www.orthomolecular.org/12all/lt/t_go.php?i=101 & e=MjY2MDA= & l=http://www.d\

octoryourself.com/riordan1.html) and

_http://www.canceraction.org.gg/recnac.htm_

(http://www.orthomolecular.org/12all/lt/t_go.php?i=101 & e=MjY2MDA= & l=http://www.c\

anceraction.org.gg/recnac.htm) . Additional

papers may be read at _http://brightspot.org/cresearch/index.shtml_

(http://www.orthomolecular.org/12all/lt/t_go.php?i=101 & e=MjY2MDA= & l=http://brigh\

tspot.org/cre

search/index.shtml) .

 

(10) Murata A, Morishige F and Yamaguchi H. (1982) Prolongation of survival

times of terminal cancer patients by administration of large doses of

ascorbate. International Journal of Vitamin and Nutrition Research Suppl., 23,

1982, p. 103-113. Also in Hanck, A., ed. (1982) Vitamin C: New Clinical

Applications. Bern: Huber, 103-113).

 

(11) Cameron E and Pauling L. (1976) Supplemental ascorbate in the

supportive treatment of cancer: prolongation of survival times in terminal

human

cancer. Proceedings of the National Academy of Sciences USA. 73:3685-3689.

Also:

Cameron E and Pauling L. (1978) Supplemental ascorbate in the supportive

treatment of cancer: Reevaluation of prolongation of survival times in terminal

human cancer. Proceedings of the National Academy of Sciences USA.

75:4538-4542. And: Cameron E and Pauling L. (1981) Survival times of terminal

lung

cancer patients treated with ascorbate. J. Intern. Acad. Prev. Med. 6: 21-27.

 

(12) Hoffer A. High doses of antioxidants including vitamin C do not

decrease the efficacy of chemotherapy. Townsend Letter for Doctors and

Patients.

_http://www.doctoryourself.com/chemo.html_

(http://www.orthomolecular.org/12all/lt/t_go.php?i=101 & e=MjY2MDA= & l=http://www.d\

octoryourself.com/chemo.html)

 

(13) Chemotherapy Doesn't Work, So Blame Vitamin C. Orthomolecular Medicine

News Service, October 7, 2008.

_http://orthomolecular.org/resources/omns/v04n12.shtml_

(http://www.orthomolecular.org/12all/lt/t_go.php?i=101 & e=MjY2MDA= & l=http://ortho\

molecular.org/resources/omns/v04n12.shtml)

 

(14) Moss RW. Antioxidants against Cancer. Equinox Press Inc. Brooklyn NY,

2000. ISBN-10: 1881025284; ISBN-13: 978-1881025283. Also: Moss RW. Questioning

Chemotherapy. Equinox Press, Brooklyn NY, 1995. ISBN-10: 188102525X;

ISBN-13: 978-1881025252.

For more information:

 

Intravenous vitamin C protocols for cancer treatment are posted at:

_http://www.doctoryourself.com/riordan1.html_

(http://www.orthomolecular.org/12all/lt/t_go.php?i=101 & e=MjY2MDA= & l=http://www.d\

octoryourself.com/riordan1.htm

l)

_http://www.canceraction.org.gg/recnac.htm_

(http://www.orthomolecular.org/12all/lt/t_go.php?i=101 & e=MjY2MDA= & l=http://www.c\

anceraction.org.gg/recnac.htm)

_http://www.doctoryourself.com/cameron.html_

(http://www.orthomolecular.org/12all/lt/t_go.php?i=101 & e=MjY2MDA= & l=http://www.d\

octoryourself.com/cameron.html)

 

 

Cameron E and Pauling L. Cancer and Vitamin C, revised edition.

Philadelphia: Camino Books, 1993. ISBN-10: 094015921X; ISBN-13: 978-0940159211

 

Hoffer A and Pauling L. Vitamin C and Cancer: Discovery, Recovery,

Controversy. Quarry Press, Kingston, ON, 1999. ISBN 1-55082-078-8 Reviewed at

_http://www.doctoryourself.com/hoffer_vitc_can.html_

(http://www.orthomolecular.org/12all/lt/t_go.php?i=101 & e=MjY2MDA= & l=http://www.d\

octoryourself.com/hoffer_vitc_ca

n.html)

 

Riordan HD, Hunninghake, R.E., Riordan NH, Jackson, J.J., Meng, X.L.,

Taylor, P., Casciari, J.J., Gonzalez MJ, Miranda-Massari, J.R., Mora, E.M.,

Norberto, R, Rivera, A. Intravenous Ascorbic Acid: Protocol for its Application

and

Use. Puerto Rico Health Sciences Journal, September 2003, 22:3. ()

Nutritional Medicine is Orthomolecular Medicine

Orthomolecular medicine uses safe, effective nutritional therapy to fight

illness. For more information: _http://www.orthomolecular.org_

(http://www.orthomolecular.org/12all/lt/t_go.php?i=101 & e=MjY2MDA= & l=http://www.o\

rthomolecular.or

g)

The peer-reviewed Orthomolecular Medicine News Service is a non-profit and

non-commercial informational resource.

Editorial Review Board:

Damien Downing, M.D.

Harold D. Foster, Ph.D.

Steve Hickey, Ph.D.

Abram Hoffer, M.D., Ph.D.

James A. Jackson, PhD

Bo H. Jonsson, MD, Ph.D

Thomas Levy, M.D., J.D.

Erik Paterson, M.D.

Gert E. Shuitemaker, Ph.D.

Andrew W. Saul, Ph.D., Editor and contact person. Email:

_omns_ (omns)

To Subscribe at no charge: _http://www.orthomolecular.org/.html_

(http://www.orthomolecular.org/12all/lt/t_go.php?i=101 & e=MjY2MDA= & l=http://www.o\

rt

homolecular.org/.html)

-----